Symlin Diabetic Treatment – Symlin Patient Information

http://www.for-diabetes.com/symlin-diabetic-treatment-symlin-patient-information

Symlin Diabetic Treatment – Symlin Patient Information

Pramlintide acetate is used with insulin and has been associated with an increased risk of insulin-induced severe hypoglycemia, particularly in patients with type 1 diabetes. When severe hypoglycemia associated with pramlintide acetate use occurs, it is seen within 3 hours following a pramlintide acetate injection. If severe hypoglycemia occurs while operating a motor vehicle, heavy machinery, or while engaging in other high-risk activities, serious injuries may occur.

Read More: http://www.for-diabetes.com/symlin-diabetic-treatment-symlin-patient-information